Management of Hepatic Encephalopathy with Rifaximin and Polyethylene Glycol (PEG) 3350

被引：0
|
作者：
Gaddis, Amy [1 ]
Howard, Tammi [1 ]
Kemmer, Nyingi [1 ]
Hernandez, Maria [1 ]
Kaiser, Tiffany [1 ]
Neff, Guy [1 ]
机构：
[1] Univ Cincinnati, Cincinnati, OH USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2010年 / 105卷
关键词：
D O I：
10.14309/00000434-201010001-00272
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
272
引用
收藏
页码：S101 / S101
页数：1
相关论文
共 50 条
  • [41] Polyethylene Glycol for Hepatic Encephalopathy A New Solution to Purge an Old Problem?
    Doran, Amy E.
    Shah, Neeral L.
    JAMA INTERNAL MEDICINE, 2014, 174 (11) : 1734 - 1735
  • [42] Polyethylene Glycol 3350 With Electrolytes Versus Polyethylene Glycol 4000 for Constipation: A Randomized, Controlled Trial
    Bekkali, Noor L. H.
    Hoekman, Daniel R.
    Liem, Olivia
    Bongers, Marloes E. J.
    van Wijk, Michiel P.
    Zegers, Bas
    Pelleboer, Rolf A.
    Verwijs, Wim
    Koot, Bart G. P.
    Voropaiev, Maksym
    Benninga, Marc A.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2018, 66 (01): : 10 - 15
  • [43] Rifaximin versus nonabsorbable disaccharides in the management of hepatic encephalopathy: a meta-analysis
    Jiang, Qian
    Jiang, Xue-Hua
    Zheng, Ming-Hua
    Jiang, Liu-Ming
    Chen, Yong-Ping
    Wang, Li
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2008, 20 (11) : 1064 - 1070
  • [44] Off-label Use of Polyethylene Glycol 3350 (Miralax®) Compared with Polyethylene Glycol-Electrolyte Lavage Solution (PEG-ELS): Tolerability Trumps Potency
    Wang, Wallace
    Irions, Eddie
    Ashley, Christopher
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 : S186 - S187
  • [45] Long-term management of hepatic encephalopathy with lactulose and/or rifaximin: a review of the evidence
    Hudson, Mark
    Schuchmann, Marcus
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 31 (04) : 434 - 450
  • [46] Is Lactulose Plus Rifaximin Better than Lactulose Alone in the Management of Hepatic Encephalopathy?
    Butt, Nauman Ismat
    Butt, Usman Ismat
    Kakar, Aniqa Anser Tufail Khan
    Malik, Tashia
    Siddiqui, Arif Mahmood
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2018, 28 (02): : 115 - 117
  • [47] Rifaximin as Treatment for Hepatic Encephalopathy: Some Considerations
    Ridola, Lorenzo
    Zullo, Angelo
    Hassan, Cesare
    SAUDI JOURNAL OF GASTROENTEROLOGY, 2013, 19 (01): : 56 - 56
  • [48] Cost Effectiveness of Rifaximin in the Treatment of Hepatic Encephalopathy
    Congly, Stephen E.
    Leise, Michael D.
    Kim, W. Ray
    HEPATOLOGY, 2013, 58 : 869A - 869A
  • [49] Rifaximin therapy and hepatic encephalopathy:Pros and cons
    Angelo Zullo
    Cesare Hassan
    Lorenzo Ridola
    Roberto Lorenzetti
    Salvatore MA Campo
    Oliviero Riggio
    World Journal of Gastrointestinal Pharmacology and Therapeutics, 2012, (04) : 62 - 67
  • [50] A Comparison of Rifaximin with Placebo for the treatment of Hepatic Encephalopathy
    Majeed, Abida
    Butt, Mishal Waheed
    Aziz, Hafiza Ayesha
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2018, 12 (01): : 362 - 364
12345